COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab
Christian Gytz Ammitzbøll(Aarhus University), Anne Troldborg(Aarhus University), Esben Uggerby Næser(Aarhus University Hospital), Susan Mikkelsen(Aarhus University Hospital), Morten Aagaard Nielsen(Aarhus University Hospital), Morgan Oliver Lauritsen(Aarhus University Hospital), Cecilie Bo Hansen(Rigshospitalet), Rasmus Klose‐Jensen(Aarhus University Hospital), Marie‐Louise From Hermansen(Aarhus University Hospital), Mads Lamm Larsen(Aarhus University), Christian Erikstrup(Aarhus University Hospital), Peter Garred(University of Copenhagen), Marianne Kragh Thomsen(Aarhus University), Mathias Hänel(Aarhus University Hospital), Janne Bille Mønster Olesen(Aarhus University Hospital), Ellen‐Margrethe Hauge(Aarhus University), Clara Elbæk Mistegaard(Aarhus University), Lars Erik Bartels(Aarhus University Hospital)
Cited by 5
Related Papers
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
|Nature Genetics|2022|396
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
|Journal of Bone and Mineral Research|2001|384
Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders
|Brain Behavior and Immunity|2019|171